| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | 1.27e-09 | 749 | 16 | 9 | GO:0005509 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.19e-07 | 323 | 16 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.62e-06 | 268 | 16 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.27e-05 | 188 | 16 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | heparin binding | 1.38e-05 | 192 | 16 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | Roundabout binding | 3.95e-05 | 12 | 16 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.95e-05 | 12 | 16 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 5.45e-05 | 14 | 16 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 7.18e-05 | 16 | 16 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.25e-04 | 21 | 16 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 2.41e-04 | 29 | 16 | 2 | GO:0043395 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 7.50e-04 | 51 | 16 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | coreceptor activity | 1.49e-03 | 72 | 16 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.53e-03 | 73 | 16 | 2 | GO:0050840 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 2.07e-03 | 85 | 16 | 2 | GO:0038024 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.12e-03 | 86 | 16 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | methylated histone binding | 2.12e-03 | 86 | 16 | 2 | GO:0035064 | |
| GeneOntologyMolecularFunction | methylation-dependent protein binding | 2.21e-03 | 88 | 16 | 2 | GO:0140034 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 2.96e-03 | 102 | 16 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.66e-03 | 891 | 16 | 4 | GO:0005198 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 7.12e-03 | 507 | 16 | 3 | GO:0030695 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 7.12e-03 | 507 | 16 | 3 | GO:0060589 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 1.16e-02 | 206 | 16 | 2 | GO:0140030 | |
| GeneOntologyMolecularFunction | histone binding | 1.86e-02 | 265 | 16 | 2 | GO:0042393 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.05e-02 | 279 | 16 | 2 | GO:0005096 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | 2.31e-02 | 1418 | 16 | 4 | GO:0030234 | |
| GeneOntologyMolecularFunction | amide binding | 2.34e-02 | 299 | 16 | 2 | GO:0033218 | |
| GeneOntologyMolecularFunction | peptide binding | 2.62e-02 | 318 | 16 | 2 | GO:0042277 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 5.84e-07 | 22 | 16 | 3 | GO:0048846 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 5.84e-07 | 22 | 16 | 3 | GO:1902284 | |
| GeneOntologyBiologicalProcess | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration | 1.69e-06 | 3 | 16 | 2 | GO:0021834 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 2.92e-06 | 134 | 16 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | axon extension | 3.01e-06 | 135 | 16 | 4 | GO:0048675 | |
| GeneOntologyBiologicalProcess | embryonic olfactory bulb interneuron precursor migration | 5.63e-06 | 5 | 16 | 2 | GO:0021831 | |
| GeneOntologyBiologicalProcess | Roundabout signaling pathway | 1.18e-05 | 7 | 16 | 2 | GO:0035385 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.63e-05 | 207 | 16 | 4 | GO:1990138 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.79e-05 | 212 | 16 | 4 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell chemotaxis | 2.02e-05 | 9 | 16 | 2 | GO:0071671 | |
| GeneOntologyBiologicalProcess | negative regulation of chemokine-mediated signaling pathway | 2.53e-05 | 10 | 16 | 2 | GO:0070100 | |
| GeneOntologyBiologicalProcess | tangential migration from the subventricular zone to the olfactory bulb | 2.53e-05 | 10 | 16 | 2 | GO:0022028 | |
| GeneOntologyBiologicalProcess | smooth muscle cell chemotaxis | 3.09e-05 | 11 | 16 | 2 | GO:0071670 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron development | 3.09e-05 | 11 | 16 | 2 | GO:0021891 | |
| GeneOntologyBiologicalProcess | chemotaxis | 3.37e-05 | 517 | 16 | 5 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 3.43e-05 | 519 | 16 | 5 | GO:0042330 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate adhesion | 3.64e-05 | 254 | 16 | 4 | GO:0010810 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 4.18e-05 | 89 | 16 | 3 | GO:0060411 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential migration | 4.38e-05 | 13 | 16 | 2 | GO:0021826 | |
| GeneOntologyBiologicalProcess | substrate-independent telencephalic tangential interneuron migration | 4.38e-05 | 13 | 16 | 2 | GO:0021843 | |
| GeneOntologyBiologicalProcess | regulation of chemokine-mediated signaling pathway | 4.38e-05 | 13 | 16 | 2 | GO:0070099 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 4.61e-05 | 92 | 16 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | axon guidance | 5.70e-05 | 285 | 16 | 4 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 5.78e-05 | 286 | 16 | 4 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of axon extension | 6.65e-05 | 104 | 16 | 3 | GO:0030516 | |
| GeneOntologyBiologicalProcess | developmental growth involved in morphogenesis | 6.86e-05 | 299 | 16 | 4 | GO:0060560 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 7.04e-05 | 301 | 16 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | regulation of cell junction assembly | 7.80e-05 | 309 | 16 | 4 | GO:1901888 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 8.74e-05 | 114 | 16 | 3 | GO:0050772 | |
| GeneOntologyBiologicalProcess | regulation of extent of cell growth | 1.07e-04 | 122 | 16 | 3 | GO:0061387 | |
| GeneOntologyBiologicalProcess | artery development | 1.38e-04 | 133 | 16 | 3 | GO:0060840 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell migration | 1.41e-04 | 134 | 16 | 3 | GO:0014910 | |
| GeneOntologyBiologicalProcess | positive regulation of cell junction assembly | 1.47e-04 | 136 | 16 | 3 | GO:1901890 | |
| GeneOntologyBiologicalProcess | retinal ganglion cell axon guidance | 1.54e-04 | 24 | 16 | 2 | GO:0031290 | |
| GeneOntologyBiologicalProcess | regulation of cell-matrix adhesion | 1.64e-04 | 141 | 16 | 3 | GO:0001952 | |
| GeneOntologyBiologicalProcess | smooth muscle cell migration | 1.78e-04 | 145 | 16 | 3 | GO:0014909 | |
| GeneOntologyBiologicalProcess | olfactory bulb interneuron differentiation | 1.81e-04 | 26 | 16 | 2 | GO:0021889 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-substrate adhesion | 1.93e-04 | 149 | 16 | 3 | GO:0010811 | |
| GeneOntologyBiologicalProcess | regulation of platelet-derived growth factor receptor signaling pathway | 2.11e-04 | 28 | 16 | 2 | GO:0010640 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 2.32e-04 | 410 | 16 | 4 | GO:0031589 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.36e-04 | 412 | 16 | 4 | GO:0090287 | |
| GeneOntologyBiologicalProcess | muscle cell migration | 2.43e-04 | 161 | 16 | 3 | GO:0014812 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 2.43e-04 | 161 | 16 | 3 | GO:0003206 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.49e-04 | 418 | 16 | 4 | GO:0051962 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.80e-04 | 169 | 16 | 3 | GO:0010977 | |
| GeneOntologyBiologicalProcess | motor neuron axon guidance | 3.31e-04 | 35 | 16 | 2 | GO:0008045 | |
| GeneOntologyBiologicalProcess | substrate-dependent cell migration | 3.31e-04 | 35 | 16 | 2 | GO:0006929 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 3.42e-04 | 454 | 16 | 4 | GO:0040013 | |
| GeneOntologyBiologicalProcess | positive regulation of vascular associated smooth muscle cell migration | 3.50e-04 | 36 | 16 | 2 | GO:1904754 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 3.90e-04 | 38 | 16 | 2 | GO:0030517 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 4.07e-04 | 192 | 16 | 3 | GO:0050770 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 4.11e-04 | 39 | 16 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | negative regulation of SMAD protein signal transduction | 4.11e-04 | 39 | 16 | 2 | GO:0060392 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 4.55e-04 | 41 | 16 | 2 | GO:0035909 | |
| GeneOntologyBiologicalProcess | negative regulation of cell growth | 5.43e-04 | 212 | 16 | 3 | GO:0030308 | |
| GeneOntologyBiologicalProcess | regulation of cell growth | 5.67e-04 | 519 | 16 | 4 | GO:0001558 | |
| GeneOntologyBiologicalProcess | aortic valve development | 5.72e-04 | 46 | 16 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | regulation of cell size | 6.46e-04 | 225 | 16 | 3 | GO:0008361 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 6.76e-04 | 50 | 16 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 7.04e-04 | 51 | 16 | 2 | GO:0050919 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 7.15e-04 | 233 | 16 | 3 | GO:0031345 | |
| GeneOntologyBiologicalProcess | olfactory bulb development | 7.60e-04 | 53 | 16 | 2 | GO:0021772 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle cell migration | 7.60e-04 | 53 | 16 | 2 | GO:0014912 | |
| GeneOntologyBiologicalProcess | axonogenesis | 7.85e-04 | 566 | 16 | 4 | GO:0007409 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 7.89e-04 | 54 | 16 | 2 | GO:0050922 | |
| GeneOntologyBiologicalProcess | cell junction assembly | 8.01e-04 | 569 | 16 | 4 | GO:0034329 | |
| GeneOntologyBiologicalProcess | positive regulation of axon extension | 8.18e-04 | 55 | 16 | 2 | GO:0045773 | |
| GeneOntologyBiologicalProcess | olfactory lobe development | 8.48e-04 | 56 | 16 | 2 | GO:0021988 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 8.48e-04 | 56 | 16 | 2 | GO:0060412 | |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 1.04e-03 | 62 | 16 | 2 | GO:0050771 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.07e-03 | 63 | 16 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 1.09e-03 | 270 | 16 | 3 | GO:0007160 | |
| GeneOntologyBiologicalProcess | regulation of vascular associated smooth muscle cell migration | 1.11e-03 | 64 | 16 | 2 | GO:1904752 | |
| GeneOntologyBiologicalProcess | cell growth | 1.14e-03 | 625 | 16 | 4 | GO:0016049 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.14e-03 | 625 | 16 | 4 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of growth | 1.25e-03 | 283 | 16 | 3 | GO:0045926 | |
| GeneOntologyBiologicalProcess | axon development | 1.26e-03 | 642 | 16 | 4 | GO:0061564 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-matrix adhesion | 1.28e-03 | 69 | 16 | 2 | GO:0001954 | |
| GeneOntologyBiologicalProcess | regulation of focal adhesion assembly | 1.32e-03 | 70 | 16 | 2 | GO:0051893 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle cell migration | 1.32e-03 | 70 | 16 | 2 | GO:1904738 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction assembly | 1.32e-03 | 70 | 16 | 2 | GO:0090109 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 1.34e-03 | 1141 | 16 | 5 | GO:0045597 | |
| GeneOntologyBiologicalProcess | platelet-derived growth factor receptor signaling pathway | 1.36e-03 | 71 | 16 | 2 | GO:0048008 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 1.40e-03 | 72 | 16 | 2 | GO:0022029 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.43e-03 | 296 | 16 | 3 | GO:0048762 | |
| GeneOntologyBiologicalProcess | positive chemotaxis | 1.51e-03 | 75 | 16 | 2 | GO:0050918 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 1.51e-03 | 75 | 16 | 2 | GO:0021885 | |
| GeneOntologyBiologicalProcess | regulation of cell-substrate junction organization | 1.51e-03 | 75 | 16 | 2 | GO:0150116 | |
| GeneOntologyCellularComponent | microfibril | 4.26e-05 | 13 | 16 | 2 | GO:0001527 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.29e-03 | 656 | 16 | 4 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.31e-03 | 658 | 16 | 4 | GO:0030312 | |
| MousePheno | diaphragmatic hernia | 1.74e-06 | 29 | 12 | 3 | MP:0003924 | |
| MousePheno | abnormal diaphragm morphology | 3.55e-05 | 78 | 12 | 3 | MP:0002279 | |
| MousePheno | herniated abdominal wall | 1.27e-04 | 20 | 12 | 2 | MP:0000757 | |
| MousePheno | abnormal thoracic aorta morphology | 1.78e-04 | 134 | 12 | 3 | MP:0010468 | |
| MousePheno | abnormal hypaxial muscle morphology | 2.07e-04 | 141 | 12 | 3 | MP:0003358 | |
| MousePheno | abnormal heart septum morphology | 2.42e-04 | 388 | 12 | 4 | MP:0006113 | |
| MousePheno | abnormal tendon morphology | 3.10e-04 | 31 | 12 | 2 | MP:0005503 | |
| MousePheno | vascular ring | 3.96e-04 | 35 | 12 | 2 | MP:0010466 | |
| MousePheno | abnormal heart and great artery attachment | 6.20e-04 | 205 | 12 | 3 | MP:0010426 | |
| MousePheno | abnormal heart and great vessel attachment | 6.47e-04 | 208 | 12 | 3 | MP:0010425 | |
| MousePheno | abnormal aorta morphology | 8.13e-04 | 225 | 12 | 3 | MP:0000272 | |
| MousePheno | abnormal systemic artery morphology | 1.94e-03 | 304 | 12 | 3 | MP:0011655 | |
| MousePheno | abnormal heart right ventricle size | 1.96e-03 | 78 | 12 | 2 | MP:0010577 | |
| MousePheno | abnormal vascular smooth muscle morphology | 2.01e-03 | 79 | 12 | 2 | MP:0005592 | |
| MousePheno | abnormal abdominal wall morphology | 2.16e-03 | 82 | 12 | 2 | MP:0003257 | |
| Domain | EGF_Ca-bd_CS | 2.09e-17 | 97 | 16 | 9 | IPR018097 | |
| Domain | EGF_CA | 2.53e-17 | 99 | 16 | 9 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.78e-17 | 106 | 16 | 9 | IPR000152 | |
| Domain | EGF_CA | 1.77e-16 | 122 | 16 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.05e-16 | 124 | 16 | 9 | IPR001881 | |
| Domain | ASX_HYDROXYL | 6.31e-15 | 100 | 16 | 8 | PS00010 | |
| Domain | EGF | 7.19e-14 | 235 | 16 | 9 | SM00181 | |
| Domain | EGF_3 | 7.19e-14 | 235 | 16 | 9 | PS50026 | |
| Domain | EGF-like_dom | 1.21e-13 | 249 | 16 | 9 | IPR000742 | |
| Domain | EGF_1 | 1.51e-13 | 255 | 16 | 9 | PS00022 | |
| Domain | EGF_2 | 2.13e-13 | 265 | 16 | 9 | PS01186 | |
| Domain | cEGF | 1.50e-11 | 26 | 16 | 5 | PF12662 | |
| Domain | cEGF | 1.50e-11 | 26 | 16 | 5 | IPR026823 | |
| Domain | EGF-like_CS | 1.53e-11 | 261 | 16 | 8 | IPR013032 | |
| Domain | Growth_fac_rcpt_ | 2.66e-11 | 156 | 16 | 7 | IPR009030 | |
| Domain | EGF_CA | 6.16e-11 | 86 | 16 | 6 | PF07645 | |
| Domain | LDLR_class-A_CS | 3.22e-08 | 40 | 16 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 5.24e-08 | 45 | 16 | 4 | PF00057 | |
| Domain | EGF | 5.31e-08 | 126 | 16 | 5 | PF00008 | |
| Domain | - | 5.73e-08 | 46 | 16 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 6.83e-08 | 48 | 16 | 4 | PS01209 | |
| Domain | LDLa | 7.43e-08 | 49 | 16 | 4 | SM00192 | |
| Domain | LDLRA_2 | 7.43e-08 | 49 | 16 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 7.43e-08 | 49 | 16 | 4 | IPR002172 | |
| Domain | DUF5050 | 6.88e-07 | 2 | 16 | 2 | PF16472 | |
| Domain | DUF5050 | 6.88e-07 | 2 | 16 | 2 | IPR032485 | |
| Domain | Ldl_recept_b | 6.22e-05 | 14 | 16 | 2 | PF00058 | |
| Domain | LDLRB | 6.22e-05 | 14 | 16 | 2 | PS51120 | |
| Domain | LY | 7.18e-05 | 15 | 16 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.18e-05 | 15 | 16 | 2 | IPR000033 | |
| Domain | CTCK_1 | 1.04e-04 | 18 | 16 | 2 | PS01185 | |
| Domain | CT | 1.57e-04 | 22 | 16 | 2 | SM00041 | |
| Domain | Cys_knot_C | 2.04e-04 | 25 | 16 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.04e-04 | 25 | 16 | 2 | PS01225 | |
| Domain | hEGF | 2.57e-04 | 28 | 16 | 2 | PF12661 | |
| Domain | LRRCT | 3.36e-04 | 32 | 16 | 2 | PF01463 | |
| Domain | LAM_G_DOMAIN | 4.75e-04 | 38 | 16 | 2 | PS50025 | |
| Domain | - | 5.01e-04 | 39 | 16 | 2 | 2.120.10.30 | |
| Domain | Laminin_G_2 | 5.27e-04 | 40 | 16 | 2 | PF02210 | |
| Domain | LamG | 6.37e-04 | 44 | 16 | 2 | SM00282 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.97e-04 | 46 | 16 | 2 | IPR011042 | |
| Domain | ConA-like_dom | 7.96e-04 | 219 | 16 | 3 | IPR013320 | |
| Domain | LRRNT | 9.24e-04 | 53 | 16 | 2 | PF01462 | |
| Domain | Laminin_G | 1.11e-03 | 58 | 16 | 2 | IPR001791 | |
| Domain | Zinc_finger_PHD-type_CS | 1.39e-03 | 65 | 16 | 2 | IPR019786 | |
| Domain | PHD | 1.84e-03 | 75 | 16 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 2.04e-03 | 79 | 16 | 2 | IPR019787 | |
| Domain | PHD | 2.58e-03 | 89 | 16 | 2 | SM00249 | |
| Domain | Cys-rich_flank_reg_C | 2.64e-03 | 90 | 16 | 2 | IPR000483 | |
| Domain | LRRCT | 2.64e-03 | 90 | 16 | 2 | SM00082 | |
| Domain | Znf_PHD | 2.70e-03 | 91 | 16 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 2.93e-03 | 95 | 16 | 2 | PS50016 | |
| Domain | - | 2.93e-03 | 95 | 16 | 2 | 2.60.120.200 | |
| Domain | ZF_PHD_1 | 2.99e-03 | 96 | 16 | 2 | PS01359 | |
| Domain | LRRNT | 3.12e-03 | 98 | 16 | 2 | IPR000372 | |
| Domain | LRRNT | 3.12e-03 | 98 | 16 | 2 | SM00013 | |
| Domain | Znf_FYVE_PHD | 6.87e-03 | 147 | 16 | 2 | IPR011011 | |
| Domain | LRR_8 | 9.19e-03 | 171 | 16 | 2 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 9.82e-03 | 177 | 16 | 2 | IPR003591 | |
| Domain | LRR_TYP | 9.82e-03 | 177 | 16 | 2 | SM00369 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.68e-06 | 37 | 13 | 3 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 7.94e-06 | 44 | 13 | 3 | M26969 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 3.52e-05 | 10 | 13 | 2 | M27348 | |
| Pathway | WP_AXON_GUIDANCE | 3.52e-05 | 72 | 13 | 3 | M48335 | |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 1.48e-04 | 20 | 13 | 2 | MM14974 | |
| Pathway | KEGG_AXON_GUIDANCE | 2.00e-04 | 129 | 13 | 3 | M5539 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.83e-04 | 32 | 13 | 2 | MM14854 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.71e-04 | 39 | 13 | 2 | MM14601 | |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 7.27e-04 | 44 | 13 | 2 | M875 | |
| Pathway | REACTOME_SIGNALING_BY_ROBO_RECEPTORS | 9.30e-04 | 218 | 13 | 3 | M2780 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 1.56e-03 | 261 | 13 | 3 | MM15676 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.33e-03 | 300 | 13 | 3 | M610 | |
| Pathway | WP_SPINAL_CORD_INJURY | 4.29e-03 | 108 | 13 | 2 | MM15954 | |
| Pathway | WP_SPINAL_CORD_INJURY | 5.02e-03 | 117 | 13 | 2 | M39341 | |
| Pubmed | 1.75e-08 | 12 | 16 | 3 | 22981605 | ||
| Pubmed | 3.62e-08 | 15 | 16 | 3 | 18345009 | ||
| Pubmed | ISL1-based LIM complexes control Slit2 transcription in developing cranial motor neurons. | 6.49e-08 | 18 | 16 | 3 | 27819291 | |
| Pubmed | Gout inheritance in an extended Chinese family analyzed by whole-exome sequencing: A case-report. | 1.98e-07 | 2 | 16 | 2 | 32569156 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 1.98e-07 | 2 | 16 | 2 | 15963947 | |
| Pubmed | 2.32e-07 | 27 | 16 | 3 | 25843547 | ||
| Pubmed | 2.60e-07 | 28 | 16 | 3 | 18617019 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 21795536 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 26542734 | ||
| Pubmed | Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain. | 5.95e-07 | 3 | 16 | 2 | 16162649 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 10349621 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 10102269 | ||
| Pubmed | Conserved modularity and potential for alternate splicing in mouse and human Slit genes. | 5.95e-07 | 3 | 16 | 2 | 12141424 | |
| Pubmed | Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion. | 5.95e-07 | 3 | 16 | 2 | 24065825 | |
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 16840550 | ||
| Pubmed | 5.95e-07 | 3 | 16 | 2 | 9813312 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 21465248 | ||
| Pubmed | Forelimb contractures and abnormal tendon collagen fibrillogenesis in fibulin-4 null mice. | 1.19e-06 | 4 | 16 | 2 | 26711913 | |
| Pubmed | SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number. | 1.19e-06 | 4 | 16 | 2 | 21664580 | |
| Pubmed | Slits contribute to the guidance of retinal ganglion cell axons in the mammalian optic tract. | 1.19e-06 | 4 | 16 | 2 | 16828733 | |
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 18566128 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 20919742 | ||
| Pubmed | 1.19e-06 | 4 | 16 | 2 | 10433822 | ||
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 11520671 | ||
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 12609596 | ||
| Pubmed | Vascular Robo4 restricts proangiogenic VEGF signaling in breast. | 1.98e-06 | 5 | 16 | 2 | 20498081 | |
| Pubmed | Extracellular Ig domains 1 and 2 of Robo are important for ligand (Slit) binding. | 1.98e-06 | 5 | 16 | 2 | 15207848 | |
| Pubmed | Slit proteins are not dominant chemorepellents for olfactory tract and spinal motor axons. | 1.98e-06 | 5 | 16 | 2 | 11748139 | |
| Pubmed | 1.98e-06 | 5 | 16 | 2 | 28234971 | ||
| Pubmed | On the topographic targeting of basal vomeronasal axons through Slit-mediated chemorepulsion. | 1.98e-06 | 5 | 16 | 2 | 12954717 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 16439476 | ||
| Pubmed | Pioneer longitudinal axons navigate using floor plate and Slit/Robo signals. | 2.97e-06 | 6 | 16 | 2 | 18842816 | |
| Pubmed | Robo2 Receptor Gates the Anatomical Divergence of Neurons Derived From a Common Precursor Origin. | 2.97e-06 | 6 | 16 | 2 | 34249921 | |
| Pubmed | Autocrine/juxtaparacrine regulation of axon fasciculation by Slit-Robo signaling. | 2.97e-06 | 6 | 16 | 2 | 22306607 | |
| Pubmed | SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. | 2.97e-06 | 6 | 16 | 2 | 18829537 | |
| Pubmed | Molecular evolution of the fibulins: implications on the functionality of the elastic fibulins. | 2.97e-06 | 6 | 16 | 2 | 20595023 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 10864954 | ||
| Pubmed | Robo1 and robo2 control the development of the lateral olfactory tract. | 2.97e-06 | 6 | 16 | 2 | 17360927 | |
| Pubmed | 2.97e-06 | 6 | 16 | 2 | 19349279 | ||
| Pubmed | Slit/Robo-mediated chemorepulsion of vagal sensory axons in the fetal gut. | 2.97e-06 | 6 | 16 | 2 | 23161783 | |
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 20606719 | ||
| Pubmed | Slit molecules prevent entrance of trunk neural crest cells in developing gut. | 4.16e-06 | 7 | 16 | 2 | 25490618 | |
| Pubmed | Tissue-Specific Roles for the Slit-Robo Pathway During Heart, Caval Vein, and Diaphragm Development. | 4.16e-06 | 7 | 16 | 2 | 35343246 | |
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 12702769 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 28676569 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 36266461 | ||
| Pubmed | 4.16e-06 | 7 | 16 | 2 | 21688288 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.29e-06 | 248 | 16 | 4 | 24006456 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 23884932 | ||
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 17581972 | ||
| Pubmed | Conserved roles for Slit and Robo proteins in midline commissural axon guidance. | 5.55e-06 | 8 | 16 | 2 | 15091338 | |
| Pubmed | Multiple Slits regulate the development of midline glial populations and the corpus callosum. | 5.55e-06 | 8 | 16 | 2 | 22349628 | |
| Pubmed | 5.55e-06 | 8 | 16 | 2 | 15162513 | ||
| Pubmed | PlexinA1 is a new Slit receptor and mediates axon guidance function of Slit C-terminal fragments. | 5.55e-06 | 8 | 16 | 2 | 25485759 | |
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 25056828 | ||
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 22806432 | ||
| Pubmed | 7.13e-06 | 9 | 16 | 2 | 10864955 | ||
| Pubmed | MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. | 7.13e-06 | 9 | 16 | 2 | 20947829 | |
| Pubmed | Collaborative and specialized functions of Robo1 and Robo2 in spinal commissural axon guidance. | 7.13e-06 | 9 | 16 | 2 | 20631173 | |
| Pubmed | Coordination of endothelial cell positioning and fate specification by the epicardium. | 8.91e-06 | 10 | 16 | 2 | 34230480 | |
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 22399681 | ||
| Pubmed | Knockdown of slit signaling during limb development leads to a reduction in humerus length. | 1.09e-05 | 11 | 16 | 2 | 33347679 | |
| Pubmed | 1.09e-05 | 11 | 16 | 2 | 24639464 | ||
| Pubmed | Molecular mechanisms controlling midline crossing by precerebellar neurons. | 1.09e-05 | 11 | 16 | 2 | 18562598 | |
| Pubmed | Global genetic analysis in mice unveils central role for cilia in congenital heart disease. | 1.26e-05 | 100 | 16 | 3 | 25807483 | |
| Pubmed | Sim1 and Sim2 are required for the correct targeting of mammillary body axons. | 1.31e-05 | 12 | 16 | 2 | 16291793 | |
| Pubmed | 1.31e-05 | 12 | 16 | 2 | 19906969 | ||
| Pubmed | Roundabout receptors are critical for foregut separation from the body wall. | 1.31e-05 | 12 | 16 | 2 | 23328398 | |
| Pubmed | Role of neuropilin-2 in the ipsilateral growth of midbrain dopaminergic axons. | 1.54e-05 | 13 | 16 | 2 | 23534961 | |
| Pubmed | 1.54e-05 | 13 | 16 | 2 | 19700621 | ||
| Pubmed | Expression of Slit and Robo genes in the developing mouse heart. | 1.54e-05 | 13 | 16 | 2 | 20941780 | |
| Pubmed | 1.80e-05 | 14 | 16 | 2 | 15082773 | ||
| Pubmed | The role of Sema3-Npn-1 signaling during diaphragm innervation and muscle development. | 1.80e-05 | 14 | 16 | 2 | 27466379 | |
| Pubmed | Complement factor H, a marker of self protects against experimental autoimmune encephalomyelitis. | 1.80e-05 | 14 | 16 | 2 | 19299737 | |
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 23821580 | ||
| Pubmed | A simple method for 3D analysis of immunolabeled axonal tracts in a transparent nervous system. | 2.08e-05 | 15 | 16 | 2 | 25456121 | |
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 23255421 | ||
| Pubmed | 2.08e-05 | 15 | 16 | 2 | 19961580 | ||
| Pubmed | 2.37e-05 | 16 | 16 | 2 | 17715346 | ||
| Pubmed | Sensory and spinal inhibitory dorsal midline crossing is independent of Robo3. | 2.69e-05 | 17 | 16 | 2 | 26257608 | |
| Pubmed | An important role of endothelial hairy-related transcription factors in mouse vascular development. | 2.69e-05 | 17 | 16 | 2 | 25264302 | |
| Pubmed | 3.02e-05 | 18 | 16 | 2 | 16854408 | ||
| Pubmed | Midline radial glia translocation and corpus callosum formation require FGF signaling. | 3.02e-05 | 18 | 16 | 2 | 16715082 | |
| Pubmed | Ezh2 orchestrates topographic migration and connectivity of mouse precerebellar neurons. | 3.38e-05 | 19 | 16 | 2 | 23307742 | |
| Pubmed | Non-cell autonomous control of precerebellar neuron migration by Slit and Robo proteins. | 3.38e-05 | 19 | 16 | 2 | 29343636 | |
| Pubmed | 3.38e-05 | 19 | 16 | 2 | 21508241 | ||
| Pubmed | 3.38e-05 | 19 | 16 | 2 | 25691540 | ||
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 3.75e-05 | 20 | 16 | 2 | 29961574 | |
| Pubmed | 3.75e-05 | 20 | 16 | 2 | 20696379 | ||
| Pubmed | FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections. | 3.75e-05 | 20 | 16 | 2 | 30392794 | |
| Pubmed | The transcription factor neurogenin 2 restricts cell migration from the cortex to the striatum. | 3.75e-05 | 20 | 16 | 2 | 11748150 | |
| Pubmed | Genetic dissection of the function of hindbrain axonal commissures. | 3.75e-05 | 20 | 16 | 2 | 20231872 | |
| Pubmed | 4.15e-05 | 21 | 16 | 2 | 18547144 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 4.15e-05 | 21 | 16 | 2 | 21337463 | |
| Pubmed | Transient neuronal populations are required to guide callosal axons: a role for semaphorin 3C. | 4.99e-05 | 23 | 16 | 2 | 19859539 | |
| Pubmed | Ca2+ homeostasis maintained by TMCO1 underlies corpus callosum development via ERK signaling. | 6.41e-05 | 26 | 16 | 2 | 35927240 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 6.92e-05 | 27 | 16 | 2 | 24741061 | |
| Pubmed | 8.00e-05 | 29 | 16 | 2 | 25336744 | ||
| Pubmed | 8.57e-05 | 30 | 16 | 2 | 23042737 | ||
| Pubmed | The transcription factor gene Nfib is essential for both lung maturation and brain development. | 8.57e-05 | 30 | 16 | 2 | 15632069 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.07e-02 | 797 | 16 | 2 | chr19p13 | |
| GeneFamily | Fibulins | 4.79e-06 | 8 | 8 | 2 | 556 | |
| GeneFamily | Low density lipoprotein receptors | 1.33e-05 | 13 | 8 | 2 | 634 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.30e-04 | 394 | 8 | 3 | 471 | |
| GeneFamily | PHD finger proteins | 6.73e-04 | 90 | 8 | 2 | 88 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.22e-09 | 196 | 16 | 6 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 9.26e-09 | 275 | 16 | 6 | M5884 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 2.24e-08 | 574 | 16 | 7 | M39056 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.98e-08 | 191 | 16 | 5 | MM17059 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.00e-07 | 200 | 16 | 5 | M5930 | |
| Coexpression | NABA_CORE_MATRISOME | 4.45e-07 | 270 | 16 | 5 | MM17057 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 5.46e-06 | 199 | 16 | 4 | M7420 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 1.59e-05 | 261 | 16 | 4 | M1834 | |
| Coexpression | NABA_MATRISOME | 2.03e-05 | 1026 | 16 | 6 | M5889 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 2.61e-05 | 296 | 16 | 4 | M41675 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.65e-05 | 117 | 16 | 3 | M39300 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 5.12e-05 | 352 | 16 | 4 | M17471 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 5.29e-05 | 355 | 16 | 4 | M45758 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 7.07e-05 | 767 | 16 | 5 | M39209 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.68e-04 | 479 | 16 | 4 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.74e-04 | 483 | 16 | 4 | MM1082 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 2.08e-04 | 194 | 16 | 3 | M39122 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 2.24e-04 | 199 | 16 | 3 | M5682 | |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN | 2.28e-04 | 200 | 16 | 3 | M5697 | |
| Coexpression | NABA_MATRISOME | 2.55e-04 | 1008 | 16 | 5 | MM17056 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 3.97e-04 | 600 | 16 | 4 | M39055 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 4.55e-04 | 52 | 16 | 2 | MM693 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 5.86e-04 | 59 | 16 | 2 | M47993 | |
| Coexpression | BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 5.86e-04 | 59 | 16 | 2 | M10156 | |
| Coexpression | NADLER_OBESITY_UP | 6.06e-04 | 60 | 16 | 2 | M1431 | |
| Coexpression | NADLER_OBESITY_UP | 7.55e-04 | 67 | 16 | 2 | MM1007 | |
| Coexpression | MAHAJAN_RESPONSE_TO_IL1A_DN | 8.24e-04 | 70 | 16 | 2 | M12107 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 7.01e-07 | 464 | 16 | 6 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 7.17e-06 | 1094 | 16 | 7 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.43e-05 | 445 | 16 | 5 | GSM777043_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.79e-05 | 814 | 16 | 6 | JC_fibro_2500_K5 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000 | 5.41e-05 | 990 | 16 | 6 | JC_fibro_1000 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | 5.54e-05 | 994 | 16 | 6 | PCBC_ratio_EB_vs_SC_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.21e-04 | 131 | 16 | 3 | ratio_MESO_vs_SC_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.41e-04 | 138 | 16 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k3 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.65e-04 | 437 | 16 | 4 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.03e-04 | 453 | 16 | 4 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 3.09e-04 | 455 | 16 | 4 | GSM777055_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 3.38e-04 | 466 | 16 | 4 | GSM777050_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 5.69e-04 | 972 | 16 | 5 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 5.77e-04 | 975 | 16 | 5 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | 5.97e-04 | 982 | 16 | 5 | PCBC_ratio_MESO-5_vs_SC_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 6.08e-04 | 986 | 16 | 5 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_200 | 6.13e-04 | 49 | 16 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_200_k1 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.52e-11 | 200 | 16 | 6 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-09 | 176 | 16 | 5 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.65e-09 | 176 | 16 | 5 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.65e-09 | 192 | 16 | 5 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.10e-09 | 195 | 16 | 5 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-09 | 198 | 16 | 5 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 6.59e-09 | 198 | 16 | 5 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 6.59e-09 | 198 | 16 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-09 | 198 | 16 | 5 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.59e-09 | 198 | 16 | 5 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-09 | 199 | 16 | 5 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.76e-09 | 199 | 16 | 5 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-09 | 200 | 16 | 5 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-09 | 200 | 16 | 5 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-09 | 200 | 16 | 5 | ec7d6a08e34bcad5b3bbff56ebef96ae17e4cefd | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-09 | 200 | 16 | 5 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-09 | 200 | 16 | 5 | 376c1a77031e090be96948b47c78ac0d393f5775 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-09 | 200 | 16 | 5 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-09 | 200 | 16 | 5 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 6.93e-09 | 200 | 16 | 5 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.93e-09 | 200 | 16 | 5 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.93e-09 | 200 | 16 | 5 | fd92d8250c6ad1e8bb46b303ac37f8dcf80387d8 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.93e-09 | 200 | 16 | 5 | 671e731977c58a0c44c36b56422085d93d999aad | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-07 | 170 | 16 | 4 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.97e-07 | 176 | 16 | 4 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-07 | 176 | 16 | 4 | 135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.97e-07 | 176 | 16 | 4 | 2287bd8382f41e36ebb0875a0133bada1ec81fa7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.44e-07 | 181 | 16 | 4 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|World / Stress and Cell class | 4.85e-07 | 185 | 16 | 4 | b8cd94cf18308b514fc61557550225794ffd2860 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.95e-07 | 186 | 16 | 4 | ff6ccfdf2509f96caa10281c29a95b432f6c6dcc | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.95e-07 | 186 | 16 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.06e-07 | 187 | 16 | 4 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 5.17e-07 | 188 | 16 | 4 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.17e-07 | 188 | 16 | 4 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 189 | 16 | 4 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 189 | 16 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.28e-07 | 189 | 16 | 4 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.28e-07 | 189 | 16 | 4 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-07 | 189 | 16 | 4 | bc54ffd7bd1627a36747a80ce5139e4a69928400 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | 3720e64129f3f3268b1dc14031a76f41c38241c2 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | 73a50426f972f08f9bb525ad5c0b774187ab5d6a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-07 | 190 | 16 | 4 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 | |
| ToppCell | facs-GAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | b55cf1fb586b724295b7b038483249847bb344fc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.39e-07 | 190 | 16 | 4 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-07 | 190 | 16 | 4 | c2cd1eb674162ee40502c3380b7245c85079c7ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 190 | 16 | 4 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.39e-07 | 190 | 16 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 191 | 16 | 4 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.50e-07 | 191 | 16 | 4 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-07 | 191 | 16 | 4 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.50e-07 | 191 | 16 | 4 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-07 | 192 | 16 | 4 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-07 | 192 | 16 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-07 | 192 | 16 | 4 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-07 | 192 | 16 | 4 | 24d682e3247a73d349e7776b9e564b6b57f4cb13 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-07 | 192 | 16 | 4 | 0b3161ce3add9f7457f4cfa5749dbb6501e3ad36 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-07 | 192 | 16 | 4 | 61c7ec6171c519b2f3e9ce623669162c0c6ba9f5 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 5.62e-07 | 192 | 16 | 4 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.62e-07 | 192 | 16 | 4 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Trachea-24m-Mesenchymal|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | e8af6ad1ae99cae13a82d0d8d7f38af9b777f0ba | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-07 | 192 | 16 | 4 | 2d9e2262f1342fe17735f21f733c029d1275e955 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.62e-07 | 192 | 16 | 4 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-07 | 192 | 16 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.62e-07 | 192 | 16 | 4 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.74e-07 | 193 | 16 | 4 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-07 | 193 | 16 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.74e-07 | 193 | 16 | 4 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | 733f557bdc80293b40ccdf560f1675793df932d6 | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | eb3c46b6fb06dc8708dc3032189b47ed93ee2357 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.74e-07 | 193 | 16 | 4 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | facs-MAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.74e-07 | 193 | 16 | 4 | b45cd02081f97904eaea2d013e1fa980505d060b | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.86e-07 | 194 | 16 | 4 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.86e-07 | 194 | 16 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-07 | 194 | 16 | 4 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.86e-07 | 194 | 16 | 4 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.86e-07 | 194 | 16 | 4 | 35b30bc954750e939f81a9a7498b8bc2ce69a299 | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c | |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.86e-07 | 194 | 16 | 4 | 85081d255fcc1e9854c0073321dd9f0feaa48866 | |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.98e-07 | 195 | 16 | 4 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-07 | 195 | 16 | 4 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.98e-07 | 195 | 16 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.98e-07 | 195 | 16 | 4 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | IPF-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.98e-07 | 195 | 16 | 4 | 9c32756edb54f0c211185d9a98073fe01fd1526a | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | 65f2f51e17f1869f3468813127b96d3048d8ad41 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | IPF-Stromal-Fibroblast|IPF / Disease state, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | f7ae604ba32b322d86d68b2b54892e7c6ab06c49 | |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.10e-07 | 196 | 16 | 4 | e4ed897900a6472738bc6be2fb4817192727225d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.10e-07 | 196 | 16 | 4 | ed6047b48b6a96baa6a90c7af784e7c34b32824d | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 6.10e-07 | 196 | 16 | 4 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-07 | 197 | 16 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | 6.23e-07 | 197 | 16 | 4 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-07 | 197 | 16 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.23e-07 | 197 | 16 | 4 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| Computational | Metal / Ca ion binding. | 3.20e-07 | 133 | 13 | 5 | MODULE_324 | |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; PC3; HT_HG-U133A | 9.49e-06 | 199 | 16 | 4 | 4543_UP | |
| Drug | DETA | 6.53e-05 | 114 | 16 | 3 | CID000004284 | |
| Drug | G 3012 | 1.01e-04 | 132 | 16 | 3 | CID000120739 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 1.38e-04 | 25 | 16 | 2 | CID000062529 | |
| Drug | Mebendazole [31431-39-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.72e-04 | 158 | 16 | 3 | 2338_UP | |
| Drug | monatepil | 1.86e-04 | 29 | 16 | 2 | CID000060810 | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 4430_DN | |
| Drug | Ellipticine [519-23-3]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 2758_UP | |
| Drug | Halcinonide [3093-35-4]; Up 200; 8.8uM; HL60; HT_HG-U133A | 2.69e-04 | 184 | 16 | 3 | 2185_UP | |
| Drug | Miconazole [22916-47-8]; Up 200; 9.6uM; PC3; HG-U133A | 3.10e-04 | 193 | 16 | 3 | 1896_UP | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Down 200; 8.6uM; PC3; HT_HG-U133A | 3.14e-04 | 194 | 16 | 3 | 4325_DN | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 3.19e-04 | 195 | 16 | 3 | 3821_DN | |
| Drug | pentamidine isethionate salt; Up 200; 100uM; MCF7; HG-U133A | 3.24e-04 | 196 | 16 | 3 | 639_UP | |
| Drug | Clonidine hydrochloride [4205-91-8]; Up 200; 15uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4478_UP | |
| Drug | Domperidone maleate; Down 200; 7.4uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 4640_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5447_UP | |
| Drug | rotenone; Down 200; 1uM; PC3; HT_HG-U133A | 3.29e-04 | 197 | 16 | 3 | 5948_DN | |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; HL60; HG-U133A | 3.34e-04 | 198 | 16 | 3 | 1721_DN | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 4529_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 2125_UP | |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; PC3; HT_HG-U133A | 3.34e-04 | 198 | 16 | 3 | 6742_DN | |
| Drug | Altretamine [654-05-6]; Up 200; 19uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 5688_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 7362_UP | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4533_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 2319_DN | |
| Drug | Ketoconazole [65277-42-1]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 2640_UP | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 1uM; PC3; HT_HG-U133A | 3.44e-04 | 200 | 16 | 3 | 3825_UP | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.81e-05 | 12 | 16 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | beta-aminoisobutyric acid measurement | 7.56e-05 | 24 | 16 | 2 | EFO_0010464 | |
| Disease | congenital diaphragmatic hernia (biomarker_via_orthology) | 7.56e-05 | 24 | 16 | 2 | DOID:3827 (biomarker_via_orthology) | |
| Disease | age at assessment, pelvic organ prolapse | 2.46e-04 | 43 | 16 | 2 | EFO_0004710, EFO_0008007 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.63e-04 | 59 | 16 | 2 | EFO_0009658, GO_0009410 | |
| Disease | asthma | 5.93e-04 | 751 | 16 | 4 | MONDO_0004979 | |
| Disease | diffuse plaque measurement | 6.15e-04 | 758 | 16 | 4 | EFO_0010699 | |
| Disease | migraine disorder, endometriosis | 7.08e-04 | 73 | 16 | 2 | EFO_0001065, MONDO_0005277 | |
| Disease | leptin measurement | 8.71e-04 | 81 | 16 | 2 | EFO_0005000 | |
| Disease | descending aortic diameter | 1.03e-03 | 88 | 16 | 2 | EFO_0021788 | |
| Disease | S-warfarin measurement | 1.25e-03 | 97 | 16 | 2 | EFO_0803323 | |
| Disease | trait in response to apixaban | 1.74e-03 | 115 | 16 | 2 | OBA_2050328 | |
| Disease | Liver carcinoma | 2.39e-03 | 507 | 16 | 3 | C2239176 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.53e-03 | 139 | 16 | 2 | DOID:3908 (is_implicated_in) | |
| Disease | serum IgG glycosylation measurement | 2.61e-03 | 523 | 16 | 3 | EFO_0005193 | |
| Disease | epilepsy (implicated_via_orthology) | 3.46e-03 | 163 | 16 | 2 | DOID:1826 (implicated_via_orthology) | |
| Disease | body weight | 4.00e-03 | 1261 | 16 | 4 | EFO_0004338 | |
| Disease | Prostatic Neoplasms | 4.14e-03 | 616 | 16 | 3 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.14e-03 | 616 | 16 | 3 | C0376358 | |
| Disease | colorectal health | 5.20e-03 | 201 | 16 | 2 | EFO_0008460 | |
| Disease | amino acid measurement | 5.41e-03 | 678 | 16 | 3 | EFO_0005134 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NESENTCQDVDECQQ | 111 | Q9UHX3 | |
| EDRDECAENVDLCDN | 1361 | Q75N90 | |
| ICDGQNNCQDNSDEE | 131 | Q86YD5 | |
| DSQNDCSDNSDEENC | 3496 | Q9NZR2 | |
| FICDGDNDCQDNSDE | 3391 | Q07954 | |
| DNDCQDNSDEANCDI | 3396 | Q07954 | |
| CEDVNECEAQRCSQE | 941 | P98095 | |
| DRQTCFDENECEQNN | 176 | Q8WWZ8 | |
| EENESALDCNSEENN | 16 | Q7L590 | |
| EESDDENAVCAAQNC | 1601 | P29375 | |
| NGNLVDECDDDQANC | 596 | O14786 | |
| DDQDSCVDVDECAQA | 116 | O95967 | |
| CTNEVNDDQDAILCE | 346 | Q9Y3Y4 | |
| NPDDCEDNDCENNAT | 996 | O75094 | |
| ETAQQLNCESCDENE | 426 | Q86VV4 | |
| LNCESCDENEDDFIQ | 431 | Q86VV4 | |
| EGENCEVNVDDCEDN | 991 | O94813 | |
| EVNVDDCEDNDCENN | 996 | O94813 | |
| DCEDNDCENNSTCVD | 1001 | O94813 | |
| VCNQQNDCGDNSDEE | 31 | O15165 |